Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Shimadzu, bioMerieux Enter Mass Spec Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Shimadzu, bioMerieux Enter Mass Spec Pact

Shimadzu and bioMerieux have entered into a partnership to commercialize a mass spectrometry system for bacterial identification in microbiology labs.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Shimadzu and bioMerieux have entered into a partnership to commercialize a mass spectrometry system for bacterial identification in microbiology labs. BioMerieux will work with Shimadzu and its subsidiary, Kratos Analytical, to adapt their MALDI-TOF mass spectrometry technology for optimized integration into the microbiology lab workflow. BioMerieux expects to launch the new solution in 2010, together with the microbial database acquired from AnagnosTec.

The collaboration brings together Shimadzu’s range of technologies, encompassing analytical and measuring instruments, including liquid chromatographs, mass spectrometers, spectrophotometers and life science instruments, and bioMerieux’s expertise in infectious diseases and extensive library of microorganisms.

“We are very proud to announce our collaboration with bioMerieux, and we expect to make a significant contribution to the field of bacterial identification as a result,” said Osamu Ando, general manager for Analytical & Measuring Instruments Division at Shimadzu Corp. “Over the past few years, MALDI-TOF MS has become a key part of our product range, and is driving the expansion of our life science business. This collaboration with bioMerieux represents a new phase in the evolution of our business by expanding it from the research market into diagnostic testing.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics